D. E. Shaw & Co., Inc. Shattuck Labs, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.52 $61,492 - $130,553	-23,651 Reduced 37.74%	39,009 $105,000
Q2 2022 Aug 15, 2022	SELL	$2.7 - $4.59 $130,048 - $221,081	-48,166 Reduced 43.46%	62,660 $254,000
Q1 2022 May 16, 2022	BUY	$4.22 - $8.89 $253,765 - $534,591	60,134 Added 118.63%	110,826 $472,000
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $423,785 - $1.07 Million	50,692 New	50,692 $431,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $50.4M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.